Stress and inflammation in coronary artery disease: A review psychoneuroendocrineimmunology-based

Frontiers in Immunology

Volumn 9, Issue SEP, 2018, Pages

  Fioranelli, Massimo ^a,b   Bottaccioli, Anna G ^b,c   Bottaccioli, Francesco ^b,d,e   Bianchi, Maria ^a   Rovesti, Miriam ^f   Roccia, Maria G ^a  

^a GUGLIELMO MARCONI UNIVERSITY   (Italy)

^b Società Italiana di Geologia Ambientale Sezione Puglia   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF PARMA   (Italy)

Author keywords

Atherosclerosis; Coronary disease; Cytokines; Immune system; Inflammation; Psychoneuroendocrineimmunology; Stress

Indexed keywords

CHOLESTEROL; CRYOPYRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ANXIETY; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CELL MIGRATION; CIRCADIAN RHYTHM; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DEPRESSION; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; IMMUNE RESPONSE; IMMUNE SYSTEM; INCIDENCE; INFLAMMATION; MAST CELL; MONOCYTE; NEUROENDOCRINOLOGY; NEUTROPHIL; REVIEW; SMOKING; STRESS; TAKOTSUBO CARDIOMYOPATHY; THROMBOSIS; VAGUS REFLEX; ANIMAL; CARDIAC MUSCLE; HEART; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOLOGY; LIPID METABOLISM; MENTAL STRESS; METABOLISM; PHYSIOLOGY; PSYCHOLOGY; PSYCHONEUROIMMUNOLOGY; RISK FACTOR; SOCIAL ENVIRONMENT;

ANIMALS; CIRCADIAN RHYTHM; CORONARY ARTERY DISEASE; HEART; HUMANS; INFLAMMATION; LIPID METABOLISM; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEUROENDOCRINOLOGY; PSYCHONEUROIMMUNOLOGY; RISK FACTORS; SOCIAL ENVIRONMENT; STRESS, PSYCHOLOGICAL;

EID: 85053069808     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.02031     Document Type: Review

References (123)

1. Alexander RW. Inflammation and coronary heart disease. N Engl J Med. (1994) 331:468-469. doi: 10.1056/NEJM199408183310709
2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. (1999) 340:115-26. doi: 10.1056/NEJM199901143400207
3. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. (2006) 83:456S-60S. doi: 10.1093/ajcn/83.2.456S
4. Li JJ. Inflammation in coronary artery diseases. Chin Med J. (2011) 124:3568-575
5. Virchow R. Cellular Pathology as Based upon Physiological and Pathological Histology. London: John Churchill (1860) 350-362
6. Cholesterol Treatment Trialists' (CTT) Collaboration, Herrington WG, Emberson J, Mihaylova B, Blackwell L, Reith C, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet (2016) 376:1670-81. doi: 10.1016/S2213-8587(16)30156-5
7. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Karstelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med. (2008) 359:2195-207. doi: 10.1056/NEJMoa0807646
8. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease: FRISC Study Group: Fragmin During Instability in Coronary artery disease. N Engl J Med. (2000) 343:1139-47. doi: 10.1056/NEJM200010193431602
9. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density' lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. (2002) 347:1557-65. doi: 10.1056/NEJMoa021993
10. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med. (2004) 350:1387-97. doi: 10.1056/NEJMoa032804
11. Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation (2002) 105:2595-9. doi: 10.1161/01.CIR.0000017493.03108.1C
12. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA (2001) 285:2481-5 doi: 10.1001/jama.285.19.2481
13. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, et al. C-reactive protein is a potent predictor of mortality' independently of and in combination with troponin T in acute coronary' syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. (1998) 31:1460-5
14. Rebuzzi AG, Quaranta G, Liuzzo G, Caligiuri G, Lanza GA, Gallimore JR, et al. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. Am J Cardiol. (1998) 82:715-9
15. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO3rd Criqui M, et al. Markers of inflammation and cardiovascular disease application to clinical and public health practice a statement for healthcare professionals from the centers for disease control and prevention and the american heart association. Circulation (2003) 107:499-511
16. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol. (2001) 88:10K-15K. doi: 10.1016/S0002-9149(01)01924-5
17. Libby P, Ridker PM. Novel inflammatory markers of coronary risk. Circulation (1999) 100:1148-50
18. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. (2000) 342:836-43. doi: 10.1056/NEJM200003233421202
19. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation (2000) 101:1767-72. doi: 10.1161/circ.101.15.1767
20. Libby P, Bornfeldt KE, Tall AR. Atherosclerosis. successes, surprises, and future challenges. Circ Res. (2016) 118:531-4. doi: 10.1161/CIRCRESAHA.116.308334
21. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature (2009) 461:747-53. doi: 10.1038/nature08494
22. Libby P, Bornfeldt KE, Tall AR. Atherosclerosis: successes, surprises, and future challenges. Circ Res. (2016) 118:531-4. doi: 10.1161/CIRCRESAHA.116.308334
23. Nikpay M, Stewart AFR, McPherson R. Partitioning the heritability of coronary artery disease highlights the importance of immune-mediated processes and epigenetic sites associated with transcriptional activity. Cardiovasc Res. (2017) 113:973-83. doi: 10.1093/cvr/cvx019
24. Epelman S, Liu PP, Mann DL. Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol. (2015) 15:117-29. doi: 10.1038/nri3800
25. Jones DP, True HD, Patel J. Leukocyte trafficking in cardiovascular disease: insights from experimental models. Mediators Inflamm. 2017:9746169. doi: 10.1155/2017/9746169
26. Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation (2011) 123:594-604. doi: 10.1161/CIRCULATIONAHA.110.982777
27. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. (2007) 81:1-5 doi: 10.1189/jlb.0306164
28. Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, Tamai T, et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature (2012) 485:251-5. doi: 10.1038/nature10992
29. Frangogiannis NG. The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities. J Cardiovasc Pharmacol. (2014) 63:185-95. doi: 10.1097/FJC.0000000000000003
30. Frangogiannis NG. Regulation of the infiammatory response in cardiac repair. Circ Res. 110:159-73. doi: 10.1161/CIRCRESAHA.111.243162
31. Bot I, Shi GP, Kovanen PT. Mast cells as effectors in atherosclerosis. Arterioscler Thromb Vasc Biol. (2015) 35:265-71. doi: 10.1161/ATVBAHA.114.303570
32. Krystel-Whittemore M, Dileepan KN, Wood JG. Mast cell: a multi-functional master cell. Front. Immunol.(2016) 6:620. doi: 10.3389/fimmu.2015.00620
33. Entman ML, Youker K, Shoji T, Kukielka G, Shappell SB, Taylor AA, et al. Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J Clin Invest. (1992) 90:1335-45. doi: 10.1172/JCI115999
34. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med. (2007) 204:3037-47. doi: 10.1084/jem.20070885
35. Epelman S, Lavine KJ, Beaudin AE, Sojka DK, Carrero JA, Calderon B, et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity (2014) 40:91-104. doi: 10.1016/j.immuni.2013.11.019
36. Svedberg FR, Guilliams M. Cellular origin of human cardiac macrophage populations. Nat. Med. (2018) 24:1091-2. doi: 10.1038/s41591-018-0143-2
37. Lavine KJ, Epelman S, Uchida K, Weber KJ, Nichols CG, Schilling JD, et al. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc Natl Acad Sci USA. (2014) 111:16029-34. doi: 10.1073/pnas.1406508111
38. Zouggari Y, Ait-Oufella H, Bonnin P, Simon T, Sage AP, Guérin C, et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med. (2013) 19:1273-80. doi: 10.1038/nm.3284
39. Cosmi L, Maggi L, Santarlasci V, Liotta F, Annunziato F. T helper cells plasticity in inflammation. Cytometry (2014) 85:36-42. doi: 10.1002/cyto.a.22348
40. Anzai A, Katsumata Y, Matsuhashi T, Ito K, Endo J, et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol. (2013) 62:24e35. doi: 10.1016/j.yjmcc.2013.04.023
41. Sànchez-Trujillo L, Vázquez-Garza E, Castillo EC, García-Rivas G, Torre-Amione G. Role of adaptive immunity in the development and progression of heart failure: new evidence. Arch Med. Res. (2017) 48:1-11. doi: 10.1016/j.arcmed.2016.12.008
42. Ramos GC, Van den Berg A, Nunes-Silva V, Weirather J, Peters L, Burkard M, et al. Myocardial aging as a T-cell-mediated phenomenon. Proc Natl Acad Sci USA. (2017) 114:E2420-9. doi: 10.1073/pnas.1621047114
43. Tsiantoulas D, Sage AP, Mallat Z, Binder CJ. Targeting B cells in atherosclerosis. Arterioscler Thromb Vasc Biol. (2015) 35:296-302 doi: 10.1161/ATVBAHA.114.303569
44. Patel PA, Hernandez AF. Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy. Eur J Heart Fail. (2013) 15:724-9. doi: 10.1093/eurjhf/hft065
45. Meeuwsen JAL, Wesseling M, Hoefer IE, de Jager SCA. Prognostic value of circulating inflammatory cells in patients with stable and acute coronary artery disease. Front Cardiovasc Med. 4:44. doi: 10.3389/fcvm.2017.00044
46. Atlas SA, Kleinert HD, Camargo MJ. Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptide. Nature (1984) 309:717-9
47. Cantin M, Gutkovvska J, Thibault G, Garcia R, Hamet P, Anand-Srivastava MB, et al. The heart as an endocrine gland. J Hypertens (1984) 2(3):S329-331
48. Masayuki S, Noriyuki O, Kenneth W. Cardiokines: recent progress in elucidating the cardiac secretome. Circulation (2012) 26:e327-32. doi: 10.1161/CIRCULATIONAHA.112.150656
49. Pham I, Sediame S, Maistre G, Roudot-Thoraval F, Chabrier PE, Carayon A, et al. Renal and vascular effects of C-type and atrial natriuretic peptides in humans. Am J Physiol. (1997) 273(4, Pt 2):R1457-64
50. Palmer B, Clegg DJ. An emerging role of natriuretic peptides: igniting the fat furnace to fuel and warm the heart. Mayo Clin Proc. (2015). 90:1666-78. doi: 10.1016/j.mayocp.2015.08.006
51. Ichiki T, Burnett JC Jr. Atrial natriuretic peptide-old but new therapeutic in cardiovascular diseases. Circ J. (2016) 81:913-9. doi: 10.1253/circj.CJ-17-0499
52. Gupta DK, Wang TJ. The natriuretic peptides and cardiometabolic health. Circ J. (2015) 79:1647-55. doi: 10.1253/circj.CJ-15-0589
53. Bader M. Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy. Ann Rev Pharmacol Toxicol. (2010) 50:439-65. doi: 10.1146/annurev.pharmtox.010909.105610
54. Shi V, McMurray JJV, Lefkowitz MP. Sacubitril/Valsartan (LCZ696) in heart failure. Handb Exp Pharmacol. (2017) 243:133-65. doi: 10.1007/164_2016_77
55. Krittanawong C, Kitai T. Pharmacogenomics of angiotensin receptor/neprilysin inhibitor and its long-term side effects. Cardiovasc Ther. (2017) 35:e12272 doi: 10.1111/1755-5922.12272
56. Obraztsov VP, Strazhesko ND. The symptomatology and diagnosis of coronary thrombosis. In: Vorobeva VA, Konchalovski MP, editors. Works of the First Congress of Russian Therapists. Moscow: Comradeship Typography of A.E Mamontov. (1910). p. 26-43
57. Schwartz BG, French WJ, Mayeda GS, Burstein S, Economides C, Bhandari AK, et al. Emotional stressors trigger cardiovascular events. Int J Clin Pract. (2012) 66:631-9. doi: 10.1111/j.1742-1241.2012.02920.x
58. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 364:937-52. doi: 10.1016/S0140-6736(04)17018-9
59. Marmot MG, Rose G, Shipley M, Hamilton PJS. Employment grade and coronary heart disease in British civil servants. J. Epidemiol. Commun Health (1978) 32:244-49. doi: 10.1136/jech.32.4.244
60. Brunner EJ. Social factors and cardiovascular morbidity. Neurosci Biobehav Rev. (2017) 74(Pt B):260-8. doi: 10.1016/j.neubiorev.2016.05.004
61. Steptoe A, Kivimàki M. Stress and cardiovascular disease: an update on current knowledge. Annu Rev Public Health (2013) 34:337-54. doi: 10.1146/annurev-publhealth-031912-114452
62. Saban KL, Mathews HL, DeVon HA, Janusek LW. Epigenetics and social context: implications for disparity in cardiovascular disease. Aging Dis. (2014) 5:346-55. doi: 10.14336/AD.2014.0500346
63. Pejtersen JH, Burr H, Hannerz H, Fishta A, Hunvitz Eller N. Update on work-related psychosocial factors and the development of ischemic heart disease: a systematic review. Cardiol Rev. (2015) 23:94-8. doi: 10.1097/CRD.0000000000000033
64. De Hert M, Detraux J, Vancampfort D. The intriguing relationship between coronary heart disease and mental disorders. Dialogues Clin Neurosci. (2018) 20:31-40
65. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations. Circulation (2014) 129:1350-69. doi: 10.1161/CIR.0000000000000019
66. Cohen BE, Edmondson D, Kronish IM. State of the art review: depression, stress, anxiety, and cardiovascular disease. Am J Hypertens. (2015) 28:1295-1302. doi: 10.1093/ajh/hpv047
67. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146538 participants in 54 observational studies. Eur Heart J. (2006) 27:2763-74. doi: 10.1093/eurheartj/ehl338
68. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA (2011) 306:1241-9. doi: 10.1001/jama.2011.1282
69. Sims M, Redmond N, Khodneva Y, Durant RW, Halanych J, Safford MM. Depressive symptoms are associated with incident coronary' heart disease or revascularization among blacks but not among whites in the reasons for geographical and racial differences in stroke study. Ann Epidemiol. (2015) 25:426-32. doi: 10.1016/j.annepidem.2015.03.014
70. O'Brien EC, Greiner MA, Sims M, Hardy NC, Shahar E, et al. Depressive Symptoms and risk of cardiovascular events in blacks: findings from the jackson heart study. Cir Cardiovasc Qual Outcomes (2015) 8:552-9. doi: 10.1161/CIRCOUTCOMES.115.001800
71. Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. (2010) 56:38-46. doi: 10.1016/j.jacc.2010.03.034
72. Janszky I, Ahnve S, Lundberg I, Hemmingsson T. Early-onset depression, anxiety and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol. (2010) 56:31-7. doi: 10.1016/j.jacc.2010.03.033
73. Nabi H, Hall M, Koskenvuo M, Singh-Manoux A, Oksanen T, Suominen S, et al. Psychological and somatic symptoms of anxiety' and risk of coronary heart disease: the health and social support prospective cohort study. Biol Psychiatr. (2010) 67:378-85. doi: 10.1016/j.biopsych.2009.07.040
74. Gradus JL, Farkas DK, Svensson E, Ehrenstein V, Lash TL, Milstein A, et al. Associations between stress disorders and cardiovascular disease events in the Danish population. BMJ Open (2015) 5:e009334. doi: 10.1136/bmjopen-2015-009334
75. Crum-Cianflone NF, Bagnell ME, Schaller E, Boyko EJ, Smith B, Maynard C, et al. Impact of combat deployment and posttraumatic stress disorder on newly reported coronary' heart disease among US active duty and reserve forces. Circulation (2014) 129:1813-20. doi: 10.1161/CIRCULATIONAHA.113.005407
76. Sumner JA, Kubzansky LD, Elkind MS, Roberts AL, Agnew-Blais J, Chen Q, et al. Trauma exposure and posttraumatic stress disorder symptoms predict onset of cardiovascular events in women. Circulation (2015) 132:251-59. doi: 10.1161/CIRCULATIONAHA.114.014492
77. Kim ES, Smith J, Kubzansky LD. Prospective study of the association between dispositional optimism and incident heart failure. Circ Heart Fail. (2014) 7:394-400. doi: 10.1161/CIRCHEARTFAILURE.113.000644
78. Hori R, Hayano J, Kimura K, Shibata N. Psychosocial factors are preventive against coronary events in Japanese men with coronary artery disease: the eastern collaborative group study 7.7-year follow-up experience. Biopsychosoc Med. (2015) 9:3. doi: 10.1186/s13030-015-0030-8
79. Svensson T, Inoue M, Sawada N, Yamagishi K, Charvat H, Saito I, et al. Coping strategies and risk of cardiovascular disease incidence and mortality: the Japan Public Health Center-based prospective Study. Eur Heart J. (2016) 37:890-9. doi: 10.1093/eurheartj/ehv724
80. Kim ES, Hawes AM, Smith J. Perceived neighbourhood social cohesion and myocardial infarction. J Epidemiol Community Health (2014) 68:1020-6. doi: 10.1136/jech-2014-204009
81. Cannon WB. The Wisdom of the Body. New York, NY: Norton (1932)
82. Selye H. A syndrome produced by diverse nocuous agents. Nature (1936) 138:32
83. Fink G (ed.). Stress: Neuroendocrinology and Neurobiology, Handbook of Stress, Vol. 2. London: Academic Press Elsevier (2017)
84. Le-Ha C, Herbison CE, Beilin LJ, Burrows S, Henley DE, Lye SJ, et al. Hypothalamic-pituitary-adrenal axis activity under resting conditions and cardiovascular risk factors in adolescents. Psychoneuroendocrinology (2016) 66:118-24. doi: 10.1016/j.psyneuen.2016.01.002
85. Reynolds RM, Labad J, Strachan MWJ, Braun A, Fowkes FGR, Lee AJ, et al. Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type2 diabetes: the edinburgh type 2 diabetes study. J Clin Endocrinol Metab. (2010) 1602-8. doi: 10.1210/jc.2009-2112
86. Vogelzangs N, Beekman ATF, Milaneschi Y, Bandinelli S, Ferrucci L, Penninx BWJ. Urinary cortisol and six-year risk of all-cause and cardiovascular mortality. J Clin Endocrinol Metab. (2010) 95:4959-64. doi: 10.1210/jc.2010-0192
87. Huo Y, Chu Y, Guo L, Liu L, Xia X, Wang T. Cortisol is associated with low frequency of interleukin 10-producing B cells in patients with atherosclerosis. Cell Biochem Funct. (2017) 35:178-83. doi: 10.1002/cbf.3262
88. De Vente W, Van, Amsterdam JGC, Olff M, Kamphuis JH, Emmelkamp PMG. Burnout is associated with reduced parasympathetic activity and reduced HPA axis responsiveness. predominantly in males. Biomed Res International. (2015) 2015:431725. doi: 10.1155/2015/431725
89. Brunner EJ, Hemingway H, Walker BR, Page M, Clarke P, Juneja M, et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome. Circulation (2002) 106:2659-65. doi: 10.1161/01.CIR.0000038364.26310.BD
90. Caslin HL, Franco RL, Crabb EB, Huang CJ, Bowen MK, Acevedo EO. The effect of obesity on inflammatory cytokine and leptin production following acute mental stress. Psychophysiol (2016) 53:151-8. doi: 10.1111/psyp.12568
91. Mure LS, Le HD, Benegiamo G, Chang MW, Rios L, Jillani N, et al. Diurnal transcriptome atlas of a primate across major neural and peripheral tissues. Science (2018) 359:eaao0318. doi: 10.1126/science.aao0318
92. Tobaldini E, Costantino G, Solbiati M, Cogliati C, Kara T, Nobili L, et al. Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases. Neurosci Biobehav Rev. (2017) 74(Pt B):321-9. doi: 10.1016/j.neubiorev.2016.07.004
93. Lao XQ, Liu X, Deng H-B, Chan T-C, Ho KF, Wang F, et al. Sleep quality sleep duration, and the risk of coronary heart disease: a prospective cohort study with 60,586 adults. J Clin Sleep Med. (2018) 14:109-17. doi: 10.5664/jcsm.6894
94. Strand LB, Tsai MK, Gunnell D, Janszky I, Wen CP, Chang SS. Self-reported sleep duration and coronary heart disease mortality: a large cohort study of 400,000 Taiwanese adults. Int J Cardiol. (2016) 207:246-51. doi: 10.1016/j.ijcard.2016.01.044
95. Dumaine JE, Ashley NT. Acute sleep fragmentation induces tissue-specific changes in cytokine gene expression and increases serum corticosterone concentration. Am J Physiol Regul Integr Comp Physiol. (2015) 308:R1062-9. doi: 10.1152/ajpregu.00049.2015
96. Minkel J, Moreta M, Muto J, Htaik O, Jones C, Basner M, et al. Sleep deprivation potentiates HPA axis stress reactivity in healthy adults. Health Psychol. (2014) 33:1430-4. doi: 10.1037/a0034219
97. Castro-Diehl C, Diez Roux AV, Redline S Seeman T, McKinley P, Sloan R, et al. Sleep duration and quality in relation to autonomic nervous system measures: the multi-ethnic study of atherosclerosis (MESA). Sleep (2016) 39:1927-40. doi: 10.5665/sleep.6218
98. Tobaldini E, Cogliati C, Fiorelli EM, Nunziata V, Wu MA, Prado M, et al. One night on-call: sleep deprivation affects cardiac autonomic control and inflammation in physicians. Eur J Intern Med. (2013) 24:664-70. doi: 10.1016/j.ejim.2013.03.011
99. Nowakowski S, Matthews KA, von Känel R, Hall MH, Thurston RC. Sleep characteristics and inflammatory biomarkers among midlife women. Sleep (2018) 41:1-9 doi: 10.1093/sleep/zsy049
100. Ardell JL, Armour JA. Neurocardiology: structure-based function. Compr Physiol. (2016) 6:1635-53. doi: 10.1002/cphy.c150046
101. Klabunde RE. Cardiovascular Physiology Concepts. 2nd Edn. Philadelphia: Lippincott Williams & Wilkins (2012). p. 124-130
102. Zou R, Shi W, Tao J, Li H, Lin X, Yang S, et al. Neurocardiology: cardiovascular changes and specific brain region infarcts. Bio Med Res Intl. (2017) 2017:5646348. doi: 10.1155/2017/5646348
103. Esler M. Mental stress and human cardiovascular disease. Neurosci Biobehav Rev. (2017) 74(Pt B):269-76. doi: 10.1016/j.neubiorev.2016.10.011
104. Shen MJ, Zipes DP. Role of the autonomic nervous system in modulation cardiac arrhythmias. Circ Res. (2014) 114:1004-21. doi: 10.1161/CIRCRESAHA.113.302549
105. Kop W, Krantz D, Nearing B, Gottdiener J, Quigley J, O'Callahan M. Effects of acute mental stress and exercise on T-wave altemans in patients with implantable cardioverter defibrillators and controls. Circulation (2004) 109:1864-9. doi: 10.1161/01.CIR.0000124726.72615.60
106. Ajijola OA, Yagishita D, Reddy NK, Yamakawa K, Vaseghi M, Downs AM, et al. Remodeling of stellate ganglion neurons after spatially targeted myocardial infarction: neuropeptide and morphologic changes. Heart Rhythm (2015) 12:1027-35. doi: 10.1016/j.hrthm.2015.01.045
107. Esler M, Eikelis N, Schlaich M, Lambert G, Alvarenga M, Kaye D, et al. Human sympathetic nerve biology. Ann N Y Acad Sci. (2008) 1148:338-48. doi: 10.1196/annals.1410.064
108. Rumantir MS, Jennings GL, Lambert GW, Kaye DM, Seals DR, Esler MD. The adrenaline hypothesis of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension. J Hypertens (2000) 18:717-23. doi: 10.1097/00004872-200018060-00009
109. York KM, Hassan M, Sheps DS. Psychobiology of depression/distress in congestive heart failure. Heart Fail Rev. (2009) 14:35-50. doi: 10.1007/s10741-008-9091-0
110. Sànchez-Barajas M, Figueroa-Vega N, Ibarra-Reynoso L, del R, Moreno-Frias C, Malacara JM. Influence of heart rate variability' and psychosocial factors on carotid stiffness, elasticity' and impedance at menopause. Arch Med Res. (2015) 46:118-26. doi: 10.1016/j.arcmed.2015.02.006
111. Guan L. Autonomic nervous system and stress to predict secondary ischemic events after transient ischemic attack or minor stroke: possible implications of heart rate variability. Front. Neurol. 9:90. doi: 10.3389/fneur.2018.00090
112. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, et al. Vagus nerve stimulation attenuates the systemic inflammatory' response to endotoxin. Nature 405:458-62. (2000) doi: 10.1038/35013070
113. Bottaccioli AG. The role of stress and emotions in cardiovascular disease. Stress management and meditation programs in prevention and treatment of cardiovascular disease. In: Fioranelli M. editor. Integrative Cardiology-A New Therapeutic Vision. Basel: Springer International Publisher (2017). p. 153-63. doi: 10.1007/978-3-319-40010-5_12
114. Strike PC, Steptoe A. Systematic review of mental stress-induced myocardial ischaemia. Eur Heart J. (2003) 24:690-703. doi: 10.1016/S0195-668X(02)00615-2
115. Pimple P, Shah A, Rooks C, Bremner J, Nye J, Ibeanu I, et al. Association between anger and mental stress-induced myocardial ischemia. Am Heart J. (2015) 169:115-21.e2. doi: 10.1016/j.ahj.2014.07.031
116. Krantz DS, Burg MM. Current perspective on mental stress-induced myocardial ischemia. Psychosom Med. (2014) 76:168-170. doi: 10.1097/PSY.0000000000000054
117. Wei J, Pimple P, Shah AJ, Rooks C, Bremner JD, Nye JA, et al. Depressive symptoms are associated with mental stress-induced myocardial ischemia after acute myocardial infarction. PLoS ONE (2014) 9:e102986. doi: 10.1371/journal.pone.0102986
118. Ramadan R, Sheps D, Esteves F, Zafari AM, Bremner JD, Vaccarino V, et al. Myocardial ischemia during mental stress: role of coronary artery' disease burden and vasomotion. J Am Heart Assoc. (2013) 2:e000321. doi: 10.1161/JAHA.113.000321
119. Wei J, Rooks C, Ramadan R, Shah AJ, Bremner JD, Quyyumi AA, et al. Meta-analysis of mental stress-induced myocardial ischemia and subsequent cardiac events in patients with coronary' artery' disease. Am J Cardiol. (2014) 114:187-92. doi: 10.1016/j.amjcard.2014.04.022
120. Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med. (2015) 373:929-38. doi: 10.1056/NEJMoa1406761
121. Bottaccioli F, Bottaccioli AG. Psiconeuroendocrinoimmunologia e scienza della cura integrata. Il Manuale, Edra, Milano (English edition in preparation) (2017)
122. Bottaccioli AG, Bottaccioli F, Minelli A. Stress and the psyche-brain-immune network in psychiatric diseases based on Psychoneuroendocrineimmunology. Ann N Y Acad Sci. (2018). doi: 10.1111/nyas.13728 [Epub ahead of print]
123. Fioranelli M (ed). Integrative Cardiology-A New Therapeutic Vision. Springer International Publisher. (2017)